The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.
about
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.A momentary biomarker for depressive moodPhenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative StressThe serotonin system in autism spectrum disorder: From biomarker to animal modelsModeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders.Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in HumansInfluencing circadian and sleep-wake regulation for prevention and intervention in mood and anxiety disorders: what makes a good homeostat?Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?Platelet studies in autism spectrum disorder patients and first-degree relativesDistinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.Heterogeneous ribonucleoprotein R regulates arylalkylamine N-acetyltransferase synthesis via internal ribosomal entry site-mediated translation in a circadian manner.Identification of likely associations between cerebral folate deficiency and complex genetic- and metabolic pathogenesis of autism spectrum disorders by utilization of a pilot interaction modeling approach.Adenosine triphosphate inhibits melatonin synthesis in the rat pineal gland.Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity.Heritability of the melatonin synthesis variability in autism spectrum disorders.Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.Shorter sleep duration is associated with social impairment and comorbidities in ASD.Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.HLA-class II haplotypes and Autism Spectrum Disorders.Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat ModelMelatonin and Comorbidities in Children with Autism Spectrum Disorder
P2860
Q26744037-DEEDBB9A-EF26-4C46-8638-736CBCB71DA5Q26765408-7A6E2511-3ED4-4C2B-BA9E-BA3D025156DFQ28073105-630482B3-4599-4992-B984-9AD5EFC9C940Q28391614-B4814418-FE99-4456-A626-06D085EBB8A0Q30846620-D2CA74B2-9BED-43A6-9DC7-2F4A5AC83427Q33704992-EC62525E-4389-44A0-8DCE-DA381CB072FFQ33839140-77134CC4-4778-4382-911A-71F3AFCF1926Q35149712-353C4FA8-C34A-4668-BE22-591AA803DB07Q35767926-07D84F62-9344-4840-9C01-557E151673BDQ35774172-C12B8523-05FA-4A78-A432-9910F52CAC16Q36203094-E003301A-1EBF-4B29-A772-67C4B23A639EQ37673635-1105C619-D862-4FC3-BA9B-F95EF352E6C3Q38829779-99786FD7-E468-4CF5-822E-2EDBA776F70EQ38879318-783C8432-A7FE-4408-B93F-68C7971A2C7EQ40144035-28F9E5B9-EF4A-4DDD-B15E-A6A694185FD7Q40500968-80765A71-3E51-486D-B1EF-1CCB75D9F9DCQ42363874-658B9EEC-AD93-4D0C-9323-8817AB5E32ECQ47140291-8DF63754-55B8-4E55-8E19-6CDC755E5D0DQ47141438-2EDFE6CE-5A3B-4730-A026-BA741E5B4612Q47730175-02088040-3F88-4C65-B8E9-125DDC76A408Q47753780-B1170694-544C-4B01-8C46-BFC3B6482642Q48968128-EA937ABC-7D23-4CD9-A7B0-5091E68F0921Q50307674-F77E2400-4758-4C02-B884-9B8C1A5EBB91Q54209528-EB6EDAF3-9D09-4DA6-B3C2-716F1EC0934BQ54992302-2976DB09-7C50-4B7F-B302-EC6407E6C8CAQ55079878-4315AE83-62C6-4810-A93B-2D953D2A1DB9Q58716287-9A641678-C9BE-44AA-8922-303DB5CD1686Q58793019-5A268ABE-A7DC-466C-BF07-2579A0140605
P2860
The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@ast
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@en
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@nl
type
label
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@ast
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@en
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@nl
prefLabel
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@ast
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@en
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@nl
P2093
P2860
P50
P921
P356
P1476
The serotonin-N-acetylserotoni ...... for autism spectrum disorders.
@en
P2093
C Boudebesse
F Amsellem
H Goubran-Botros
H Laouamri
J Callebert
J-M Launay
K Le Dudal
N Ngo-Nguyen
P2860
P2888
P356
10.1038/TP.2014.120
P577
2014-11-11T00:00:00Z
P5875
P6179
1005652090